In people with type 1 diabetes mellitus, the delay in intestinal glucose absorption with first- and second-generation α-glucosidase inhibitors after a meal can decrease postprandial glucose excursions and insulin requirements [87,88]. This evidence concerns the gene INS and type 1 diabetes mellitus.